Bank of America
PMN icon

Bank of America’s ProMIS Neurosciences PMN Stock Holding History

Bank of America’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-67
Closed -$708 – 8127
2025
Q3 		$708 Hold
67
– – ﹤0.01% 7533
2025
Q2 		$805 Hold
67
– – ﹤0.01% 7575
2025
Q1 		$1.16K Hold
67
– – ﹤0.01% 7401
2024
Q4 		$1.58K Hold
67
– – ﹤0.01% 7228
2024
Q3 		$2.08K Hold
67
– – ﹤0.01% 7124
2024
Q2 		$2.5K Hold
67
– – ﹤0.01% 7110
2024
Q1 		$3.18K Hold
67
– – ﹤0.01% 7062
2023
Q4 		$1.92K Hold
67
– – ﹤0.01% 7132
2023
Q3 		$3.3K Sell
67
-474
-88% -$30.8K ﹤0.01% 7069
2023
Q2 		$52.4K Sell
541
-48
-8% -$6.38K ﹤0.01% 6451
2023
Q1 		$69.6K Buy
589
+63
+12% +$7.74K ﹤0.01% 6385
2022
Q4 		$57.1K Sell
526
-48
-8% -$6.71K ﹤0.01% 6431
2022
Q3 		$88K Buy
+574
New +$84.6K ﹤0.01% 6402

Other funds holding PMN

ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
DEM
Disciplined Equity Management Neptune Beach, Florida $226M AUM 27.21% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America's PMN Position: Q4 2025 in Review

Bank of America sold out of ProMIS Neurosciences (PMN) in Q4 2025, closing a stake of 67 shares — an estimated $708 sold.

Bank of America first reported a position in PMN in Q3 2022 and held it in 13 quarters. The position peaked at $88K in Q3 2022. 9 funds tracked by Wall St. Rank hold PMN as of Q4 2025.

  • Bank of America reported no remaining ProMIS Neurosciences position as of Q4 2025 after selling out during the quarter.
  • Bank of America sold 67 ProMIS Neurosciences shares in Q4 2025, an estimated $708.
  • Bank of America first reported a position in ProMIS Neurosciences in Q3 2022 and held it in 13 quarters.
  • Bank of America's ProMIS Neurosciences position peaked at $88K in Q3 2022.
  • 9 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q4 2025.

Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.